

IN BRIEF: Okyo Pharma plans to file new drug application in 2022


TRADING UPDATES: Great Western notes good assays; Guild signs Villalba


EXECUTIVE CHANGES: GCP Infrastructure picks Rothschild banker as chair


OKYO Pharma reports widened annual loss despite R&D costs drop


TRADING UPDATES: Gaming Realms BetMGM deal; Argo bitcoin-backed loan


EXECUTIVE CHANGES: LPA, Brewin Dolphin make new appointments to board


IN BRIEF: Okyo Pharma posts positive data for OK-201 in animal model


EXECUTIVE CHANGES: F&C Investment Trust hires CBI chief economist